Skip to content

Clinical study on innovative scheme of trigger point bloodletting in the treatment of primary trigeminal neuralgia

Clinical study on innovative scheme of trigger point bloodletting in the treatment of primary trigeminal neuralgia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000673
Enrollment
Unknown
Registered
2025-04-07
Start date
2025-04-28
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary trigeminal neuralgia

Interventions

Sponsors

Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: ( 1 ) Patients who meet the diagnostic criteria of classic trigeminal neuralgia or idiopathic trigeminal neuralgia regardless of gender ; ( 2 ) Patients with no obvious organic lesions on cranial MRI ; ( 3 ) In the past 1 month the pain occurred every day and the average VAS score in the past 48 hours was = 4 points ( 0 point was not painful 10 points were the most painful ) and if the patient used carbamazepine at the time of enrollment the average VAS score in the past 48 hours was = 8 points ; ( 4 ) Patients aged 18-75 years ; ( 5 ) Patients who had not received primary trigeminal neuralgia-related surgery before ; ( 6 ) Patients who signed the informed consent and voluntarily participated in this study. Those who meet the above 6 items at the same time can be included in this study.

Exclusion criteria

Exclusion criteria: ( 1 ) Patients with secondary trigeminal neuralgia caused by other diseases such as intracranial tumors and multiple sclerosis ; ( 2 ) Patients with painful trigeminal neuralgia due to herpes zoster post-traumatic etc. ; ( 3 ) Patients with other diseases such as glossopharyngeal neuralgia temporomandibular joint disorder sinusitis apical periodontitis and cranial neuropathy caused by facial pain ; ( 4 ) Lactating or pregnant women ; ( 5 ) Patients with severe diseases or poor control of underlying diseases ; ( 6 ) Patients with four positive infections severe coagulation dysfunction and obvious abnormal platelets ; ( 7 ) Patients who is participating in other medical trials. Anyone who meets any of the above 1 items shall be excluded.

Design outcomes

Primary

MeasureTime frame
Brief pain inventory-Facial(BPI-Facial);

Secondary

MeasureTime frame
Response rate;Visual analogue scale(VAS);Self-Rating Depression Scale(SDS);Acupuncture expectant value;Cure rate;Self-Rating Anxiety Scale(SAS);Acceptance of treatment plan;36-Item Short Form Survey;Recurrence rate;

Countries

China

Contacts

Public ContactHuilin Liu

Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University

liuhuilin@bjzhongyi.com+86 136 8139 5789

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026